We’re thrilled to share that Reglagene was selected to participate in the Brain Tumour Research Novel Therapeutics Accelerator on November 6th in Boston!

With almost 700 attendees at the Texas Life Science forum, it was an honor to have the opportunity to be a presenting company! Many thanks to Ann Tanabe with BioHouston and Brad Burke with Rice Alliance for Technology and Entrepreneurship for putting together a top tier event!

Earlier this month, our CEO, Richard Austin, delivered a powerful pitch at the IC3 Life Science Summit in Dallas, showcasing our mission to redefine brain cancer treatment. A huge thank you to BioNTX for hosting an incredible event and for bringing together visionary leaders in life sciences.

Thank you, Arizona! Last month, Reglagene’s CEO Richard Austin had the privilege of presenting at Arizona BioIndustry Association (AZBio)’s White Hat Conference, and we couldn’t be more grateful.

Grateful to have participated in the Rocky Mountain Life Sciences Investor and Partnering Conference in Breckenridge, Colorado! The Reglagene team had valuable conversations with industry leaders and investors, and CEO Richard Austin shared exciting updates on our lead asset in preclinical development. We're energized by the momentum and eager for what's next!

Thank you, BioCentury Inc., Nashville! The Reglagene team had a great three days engaging in insightful discussions with key stakeholders and industry leaders. CEO Richard Austin took the stage to share exciting updates on our lead asset currently in preclinical development.

We are excited to welcome Ben Maurey to Reglagene as our commercial-focused advisor on our Advisory Board. Ben comes to Reglagene after 8 years in the oncology space with a wide variety of roles and responsibilities.

Thinking Small has lead to the biggest breakthrough. Yesterday, Reglagene's CEO Richard Austin presented at the BIO International Convention in San Diego. Here, he discussed how Reglagene's therapy has the unique ability to cross through the blood-brain barrier and fight brain cancer. Reach out to learn more!

Thank you Angel Capital Association for selecting Reglagene as one of your Innovation Funders Showcase companies! CEO Richard Austin captivated the audience in Columbus, Ohio with a presentation on how "Thinking Small" has changed the way we think about treating brain cancer.